Lixivaptan (C007B-550081)

Catalog No.: C007B-550081
Mfr. No.: L353946-25mg
Mfr. Name: Aladdin Scientific
Qty/UOM: 1
UOM: EA

Price: $321.71

List Price: $357.46

Lixivaptan (VPA-985, WAY-VPA 985) is an orally active and selective vasopressin receptor V2 antagonist, with IC50 values of 1.2 and 2.

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Lixivaptan (VPA-985, WAY-VPA 985) is an orally active and selective vasopressin receptor V2 antagonist, with IC50 values of 1.2 and 2.3 nM for human and rat V2, respectively.

Specification: Moligand™, ≥98%

Molecular Formula: C27H21ClFN3O2

Molecular Weight: 473.93

PubChem CID: 172997

Isomeric SMILES: CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/L353946-SCI_1fe93dffc8aef818f0333df704597e0f.pdf

UPC:: 51161723
Condition:: New
Availability:: 5-10 days
Weight:: 0.07 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: L353946-25mg
CAS:: 168079-32-1
Product Size:: 25mg
Hazard Statement Codes:: H302
Precautionary Statement Codes:: P501:P301+P312:P330:P270:P264

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."